About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Urology Care Devices and Platforms Market Size, Share and Forecast to 2032
Urology Care Devices and Platforms Market

Urology Care Devices and Platforms Market Size, Share & Trends Analysis Report By Products (Devices, Platforms), By Applications (Treatment, Diagnosis and Monitoring), By Indication (Kidney Diseases, Urological Cancer and Benign Prostatic Hyperplasia, Pelvic Organ Prolapse, Other Diseases), By End-User (Hospitals, Ambulatory Surgery Centers, and Clinics, Dialysis Centers, Homecare Settings) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI54483DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Urology Care Devices and Platforms Market Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Devices
        1. By Value
      3. Platforms
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Treatment
        1. By Value
      3. Diagnosis and Monitoring
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Kidney Diseases
        1. By Value
      3. Urological Cancer and Benign Prostatic Hyperplasia
        1. By Value
      4. Pelvic Organ Prolapse
        1. By Value
      5. Other Diseases
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals, Ambulatory Surgery Centers, and Clinics
        1. By Value
      3. Dialysis Centers
        1. By Value
      4. Homecare Settings
        1. By Value
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Devices
        1. By Value
      3. Platforms
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Treatment
        1. By Value
      3. Diagnosis and Monitoring
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Kidney Diseases
        1. By Value
      3. Urological Cancer and Benign Prostatic Hyperplasia
        1. By Value
      4. Pelvic Organ Prolapse
        1. By Value
      5. Other Diseases
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals, Ambulatory Surgery Centers, and Clinics
        1. By Value
      3. Dialysis Centers
        1. By Value
      4. Homecare Settings
        1. By Value
    6. U.S.
      1. By Products
        1. Introduction
          1. Products By Value
        2. Devices
          1. By Value
        3. Platforms
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Treatment
          1. By Value
        3. Diagnosis and Monitoring
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Kidney Diseases
          1. By Value
        3. Urological Cancer and Benign Prostatic Hyperplasia
          1. By Value
        4. Pelvic Organ Prolapse
          1. By Value
        5. Other Diseases
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals, Ambulatory Surgery Centers, and Clinics
          1. By Value
        3. Dialysis Centers
          1. By Value
        4. Homecare Settings
          1. By Value
    7. Canada
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Devices
        1. By Value
      3. Platforms
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Treatment
        1. By Value
      3. Diagnosis and Monitoring
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Kidney Diseases
        1. By Value
      3. Urological Cancer and Benign Prostatic Hyperplasia
        1. By Value
      4. Pelvic Organ Prolapse
        1. By Value
      5. Other Diseases
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals, Ambulatory Surgery Centers, and Clinics
        1. By Value
      3. Dialysis Centers
        1. By Value
      4. Homecare Settings
        1. By Value
    6. U.K.
      1. By Products
        1. Introduction
          1. Products By Value
        2. Devices
          1. By Value
        3. Platforms
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Treatment
          1. By Value
        3. Diagnosis and Monitoring
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Kidney Diseases
          1. By Value
        3. Urological Cancer and Benign Prostatic Hyperplasia
          1. By Value
        4. Pelvic Organ Prolapse
          1. By Value
        5. Other Diseases
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals, Ambulatory Surgery Centers, and Clinics
          1. By Value
        3. Dialysis Centers
          1. By Value
        4. Homecare Settings
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Devices
        1. By Value
      3. Platforms
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Treatment
        1. By Value
      3. Diagnosis and Monitoring
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Kidney Diseases
        1. By Value
      3. Urological Cancer and Benign Prostatic Hyperplasia
        1. By Value
      4. Pelvic Organ Prolapse
        1. By Value
      5. Other Diseases
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals, Ambulatory Surgery Centers, and Clinics
        1. By Value
      3. Dialysis Centers
        1. By Value
      4. Homecare Settings
        1. By Value
    6. China
      1. By Products
        1. Introduction
          1. Products By Value
        2. Devices
          1. By Value
        3. Platforms
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Treatment
          1. By Value
        3. Diagnosis and Monitoring
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Kidney Diseases
          1. By Value
        3. Urological Cancer and Benign Prostatic Hyperplasia
          1. By Value
        4. Pelvic Organ Prolapse
          1. By Value
        5. Other Diseases
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals, Ambulatory Surgery Centers, and Clinics
          1. By Value
        3. Dialysis Centers
          1. By Value
        4. Homecare Settings
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Devices
        1. By Value
      3. Platforms
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Treatment
        1. By Value
      3. Diagnosis and Monitoring
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Kidney Diseases
        1. By Value
      3. Urological Cancer and Benign Prostatic Hyperplasia
        1. By Value
      4. Pelvic Organ Prolapse
        1. By Value
      5. Other Diseases
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals, Ambulatory Surgery Centers, and Clinics
        1. By Value
      3. Dialysis Centers
        1. By Value
      4. Homecare Settings
        1. By Value
    6. UAE
      1. By Products
        1. Introduction
          1. Products By Value
        2. Devices
          1. By Value
        3. Platforms
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Treatment
          1. By Value
        3. Diagnosis and Monitoring
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Kidney Diseases
          1. By Value
        3. Urological Cancer and Benign Prostatic Hyperplasia
          1. By Value
        4. Pelvic Organ Prolapse
          1. By Value
        5. Other Diseases
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals, Ambulatory Surgery Centers, and Clinics
          1. By Value
        3. Dialysis Centers
          1. By Value
        4. Homecare Settings
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Devices
        1. By Value
      3. Platforms
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Treatment
        1. By Value
      3. Diagnosis and Monitoring
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Kidney Diseases
        1. By Value
      3. Urological Cancer and Benign Prostatic Hyperplasia
        1. By Value
      4. Pelvic Organ Prolapse
        1. By Value
      5. Other Diseases
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals, Ambulatory Surgery Centers, and Clinics
        1. By Value
      3. Dialysis Centers
        1. By Value
      4. Homecare Settings
        1. By Value
    6. Brazil
      1. By Products
        1. Introduction
          1. Products By Value
        2. Devices
          1. By Value
        3. Platforms
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Treatment
          1. By Value
        3. Diagnosis and Monitoring
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Kidney Diseases
          1. By Value
        3. Urological Cancer and Benign Prostatic Hyperplasia
          1. By Value
        4. Pelvic Organ Prolapse
          1. By Value
        5. Other Diseases
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals, Ambulatory Surgery Centers, and Clinics
          1. By Value
        3. Dialysis Centers
          1. By Value
        4. Homecare Settings
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Urology Care Devices and Platforms Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. B.Braun Melsungen AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Boston Scientific Corporation
    3. Cardinal Health Inc.
    4. Axonics Modulation Technologies Inc.
    5. Micron Medical
    6. Fresenius Medical Care AG & Co. KGaA
    7. Intuitive Surgical Inc.
    8. Medtronic plc.
    9. Baxter International Inc.
    10. Olympus Corporation
    11. Becton
    12. Dickinson and Company
    13. others.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global emerging sleep apnea devices and platforms market size was valued at USD 6190 million in 2021. It is estimated to reach an expected USD 14476 million by 2030 at a CAGR of 9.9% during the forecast period (2022-2030). Sleep apnea is "an inv
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.